Development and Adaptation of I-STRONG for SCD
Integrative Training Program for Pediatric Sickle Cell Pain (I-STRONG for SCD): Optimizing Feasibility and Acceptability
3 other identifiers
interventional
45
1 country
2
Brief Summary
This study develops and tests the feasibility and acceptability of an adapted intervention, Integrative Strong Body and Mind Training (I-STRONG), in adolescents with pain from sickle cell disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2023
CompletedFirst Submitted
Initial submission to the registry
October 26, 2023
CompletedFirst Posted
Study publicly available on registry
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2024
CompletedResults Posted
Study results publicly available
December 19, 2025
CompletedDecember 19, 2025
December 1, 2025
1 year
October 26, 2023
June 13, 2025
December 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brief Pain Inventory (BPI) Pain Severity Score
Pain intensity is rated with the pain severity item of the Brief Pain Inventory (BPI). The single item is scored on a scale from 0 to 10 where no pain = 0 and severe pain = 10.
Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)
Secondary Outcomes (11)
Brief Pain Inventory (BPI) Pain Interference Score
Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)
Patient Health Questionnaire (PHQ-8) Score
Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)
General Anxiety Disorder (GAD-2) Score
Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)
Pain Catastrophizing Scale Score
Baseline, Post-treatment (Week 8), 3 Months Post-Treatment (Month 5)
Pediatric Quality of Life Inventory (PedsQL) Score
Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)
- +6 more secondary outcomes
Study Arms (2)
Development of I-STRONG for SCD
NO INTERVENTIONAdolescents with sickle cell disease and their parents participating completing in-depth interviews over two sessions as part of adapting an integrative, multicomponent, behavioral intervention combining mind-body, cognitive, and behavioral coping skills with neuromuscular exercise training for adolescents with chronic SCD pain.
I-STRONG for SCD
EXPERIMENTALAdolescents with sickle cell disease and their parents participating in a multi-component intervention that includes mind-body, cognitive-behavioral, and neuromuscular movement training.
Interventions
I-STRONG for SCD is a group-based, multi-component intervention that includes mind-body, cognitive-behavioral, and neuromuscular movement training. The intervention includes 16 sessions that occur over 8 weeks. Adolescents attend every session and parents attend 6 of the 16 sessions.
Eligibility Criteria
You may qualify if:
- Diagnosed with SCD (any genotype)
- Score of at least 3 (indicating medium to high risk for chronic pain) on the Pediatric Pain Screening Tool
- Stable disease-modifying treatments, if applicable, as defined by no newly initiated or significantly increased dosages (mg/kg) in the past 3 months (Aim 2 only)
- English fluency (Aim 2 only)
You may not qualify if:
- Comorbid medical conditions typically associated with pain but unrelated to SCD (e.g., rheumatologic disorders or inflammatory bowel disease)
- Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation (e.g., severe avascular necrosis with limited or non-weight bearing restrictions, significant cognitive or developmental limitations, active suicidal ideation) (Aim 2 only)
- Adolescent receiving active treatment (e.g., weekly appointments with a provider) for nonpharmacological therapies (e.g, structured behavioral pain management, physical therapy, or acupuncture program) that overlap with the active phase of the study intervention (Aim 2 only)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Children's Healthcare of Atlanta (CHOA)
Atlanta, Georgia, 30322, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Related Publications (1)
Mooney JT, Sinha C, Bakshi N, Nunez A, Adkins T, Thomas S, Beasley K, Akintobi T, Crosby L, Kashikar-Zuck S, Dampier C, Myer GD, Kesar T, Quinn CT, Sil S. Physical activity among adolescents and young adults living with chronic pain and sickle cell disease: a qualitative examination. J Pediatr Psychol. 2025 Dec 1;50(12):1079-1087. doi: 10.1093/jpepsy/jsaf055.
PMID: 40694814RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Soumitri Sil, PhD
- Organization
- Emory University
Study Officials
- PRINCIPAL INVESTIGATOR
Soumitri Sil, PhD
Emory University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 26, 2023
First Posted
November 1, 2023
Study Start
June 8, 2023
Primary Completion
June 14, 2024
Study Completion
June 14, 2024
Last Updated
December 19, 2025
Results First Posted
December 19, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be available for sharing one year after the end date for this study.
- Access Criteria
- Data for sharing will be in a public use, NIH HEAL-approved data repository.
Deidentified individual participant data will be available for sharing including study-level metadata and NIH Helping to End Addiction Long-term (HEAL) Common Data Elements.